Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$851M |
| 2 |
Apple
AAPL
|
+$663M |
| 3 |
UnitedHealth
UNH
|
+$206M |
| 4 |
Cisco
CSCO
|
+$192M |
| 5 |
Johnson & Johnson
JNJ
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$559M |
| 2 |
Broadcom
AVGO
|
+$224M |
| 3 |
United Rentals
URI
|
+$189M |
| 4 |
CRH
CRH
|
+$177M |
| 5 |
Pfizer
PFE
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.61% |
| 2 | Financials | 17.11% |
| 3 | Industrials | 13.24% |
| 4 | Consumer Discretionary | 11.1% |
| 5 | Healthcare | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Viridian Therapeutics
VRDN
$2.2B
| $176K | ﹤0.01% |
10,070
| – | – |
|
3202
Tyra Biosciences
TYRA
$1.97B
| $176K | ﹤0.01% |
10,750
+141
| +1% | +$2.31K |
|
|
DRD
3203
DRDGold
DRD
$1.81B
| $175K | ﹤0.01% |
+21,402
| New | +$162K |
|
|
CYPH
3204
Cypherpunk Technologies Inc
CYPH
$66.6M
| $175K | ﹤0.01% |
+65,617
| New | +$197K |
|
3205
NCS Multistage Holdings
NCSM
$119M
| $170K | ﹤0.01% |
10,639
-704
| -6% | -$11.1K |
|
3206
Solid Power
SLDP
$463M
| $168K | ﹤0.01% |
82,858
-26,363
| -24% | -$40.1K |
|
3207
Getty Images
GETY
$158M
| $167K | ﹤0.01% |
40,180
+24,847
| +162% | +$115K |
|
|
PFIE
3208
DELISTED
Profire Energy, Inc
PFIE
| $166K | ﹤0.01% |
89,679
-122,618
| -58% | -$194K |
|
3209
Grupo Aval
AVAL
$6.11B
| $165K | ﹤0.01% |
71,289
+1,379
| +2% | +$3.44K |
|
|
IMMP
3210
Immutep
IMMP
$56M
| $163K | ﹤0.01% |
70,005
| – | – |
|
|
ALLK
3211
DELISTED
Allakos
ALLK
| $161K | ﹤0.01% |
127,992
-113,958
| -47% | -$177K |
|
3212
US Gold Corp
USAU
$223M
| $160K | ﹤0.01% |
43,528
+8,481
| +24% | +$31K |
|
3213
PDS Biotechnology
PDSB
$39.1M
| $157K | ﹤0.01% |
39,641
-2,523
| -6% | -$13K |
|
3214
MediciNova
MNOV
$66M
| $156K | ﹤0.01% |
107,694
-44,836
| -29% | -$63.7K |
|
3215
US Global Investors
GROW
$35.8M
| $155K | ﹤0.01% |
55,684
+8,012
| +17% | +$21.8K |
|
3216
Santander
BSBR
$37.8B
| $154K | ﹤0.01% |
+26,969
| New | +$158K |
|
3217
Rhinebeck Bancorp
RBKB
$195M
| $154K | ﹤0.01% |
18,185
| – | – |
|
|
SGMA
3218
DELISTED
Sigmatron International
SGMA
| $153K | ﹤0.01% |
42,054
| – | – |
|
3219
Zevra Therapeutics
ZVRA
$570M
| $150K | ﹤0.01% |
25,944
-17,661
| -41% | -$109K |
|
3220
Design Therapeutics
DSGN
$788M
| $149K | ﹤0.01% |
36,855
-4,993
| -12% | -$13.3K |
|
3221
Barnwell Industries
BRN
$13.9M
| $147K | ﹤0.01% |
62,447
| – | – |
|
3222
Comstock Holding Companies
CHCI
$151M
| $146K | ﹤0.01% |
28,959
+155
| +0.5% | +$736 |
|
3223
IRIDEX
IRIX
$14.5M
| $144K | ﹤0.01% |
48,327
| – | – |
|
3224
Home Federal Bancorp
HFBL
$70.2M
| $142K | ﹤0.01% |
11,496
| – | – |
|
|
MRSN
3225
DELISTED
Mersana Therapeutics
MRSN
| $140K | ﹤0.01% |
1,250
-2,817
| -69% | -$280K |
|
Similar funds
Dimensional Fund Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Dimensional Fund Advisors held 3,470 positions worth $369B, up 7.9% from $342B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 4.1%. Dimensional Fund Advisors opened 58 new positions and exited 83, leaving the 3,470-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2024 buy was Arcadium Lithium plc: 8,775,487 shares worth $37.8M.
- Dimensional Fund Advisors added most to NVIDIA in Q1 2024, an estimated $851M increase.
- Dimensional Fund Advisors's biggest Q1 2024 reduction was Meta Platforms (Facebook), cutting an estimated $559M.
- Dimensional Fund Advisors fully exited Textainer Group Holdings limited in Q1 2024, selling an estimated $161M.
- Dimensional Fund Advisors's ten largest holdings make up 13% of its $369B portfolio in Q1 2024.
- Dimensional Fund Advisors opened 58 new positions and closed 83 in Q1 2024.
- Dimensional Fund Advisors's portfolio value rose 7.9% quarter-over-quarter to $369B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2024, filed 10 May 2024.